NCT00315952View on ClinicalTrials.gov

Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

December 31, 2006

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Exubera

Trial Locations (1)

15213

University of Pittsburgh, Pittsburgh

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Pittsburgh

OTHER

NCT00315952 - Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 Diabetes | Biotech Hunter | Biotech Hunter